The Association for Accessible Medicines (AAM) is a leading organization that focuses on improving access to safe, quality, and effective medicine. They work towards promoting competition in the pharmaceutical industry by lowering barriers to entry for manufacturers of generic and biosimilar medicines, while also combating anti-competitive practices by some brand drug companies. AAM aims to protect the low cost of generic and biosimilar medicines, driving down the cost of developing new ones and expanding access to as many people as possible.
With a strong emphasis on the positive impact of affordable generic and biosimilar medicines, AAM serves as a trusted partner and established authority within the pharmaceutical field. They provide accurate and timely data to educate policymakers and promote general public knowledge about the benefits of these medicines. By improving access to medicine, AAM believes that more people in more places can live healthier and longer lives.
Generated from the website